KAUST and EPFL Blue Brain Project researchers propose a new theory about a 'secret language' used by cells for internal communication regarding the external world. Using a computational model, they suggest that metabolic pathways can code details about neuromodulators that stimulate energy consumption. The model focuses on astrocytes and their cooperation with neurons in fueling the brain. Why it matters: This suggests a new avenue for understanding information processing in the brain and how cells contribute to the energy efficiency of brains compared to computers.
KAUST researchers collaborated to identify molecular pathways for plant biofortification of vitamin A. A KAUST group demonstrated high pressure conversion of carbon dioxide into useful products. Another team designed a biosensor using metal oxide transistors to detect glucose in saliva. Why it matters: These projects highlight KAUST's contributions to biotechnology, environmental sustainability, and healthcare through advanced materials and molecular techniques.
KAUST researchers are exploring the potential of algae for various high-value applications, including animal feed, crop fertilizers, and waste remediation. Claudio Grunewald directs a project focused on producing high-protein algae for agriculture. Kyle Lauersen brings expertise in algal synthetic biology and metabolic engineering. Why it matters: Investment in algae research and biotechnology could yield significant returns for Saudi Arabia, contributing to sustainable solutions and economic diversification.
KAUST researchers have developed a technology to convert spoiled dairy and fruit beverages into valuable short-chain and medium-chain carboxylic acids (SCCAs and MCCAs). These acids can be used for animal feed, aviation fuel, and pharmaceuticals, with SCCAs valued at $300 per ton and MCCAs having 10x higher value. A pilot study is underway at KAUST, utilizing over 500 liters of waste per week from regional companies. Why it matters: This innovation supports Saudi Arabia's goal to eliminate 90% of landfill waste by 2040 and promotes a circular economy by transforming food waste into high-value products.
KAUST's Laboratory of Stem Cells and Diseases, led by Assistant Professor Antonio Adamo, uses induced pluripotent stem cells (iPSCs) to model diseases like diabetes. The lab employs a reprogramming technique to revert patient fibroblasts into iPSCs, enabling the study of disease progression in vitro. Adamo's research focuses on enzymes and disregulated transcriptional/epigenetic mechanisms to understand disease onset. Why it matters: This research contributes to regenerative medicine and offers insights into metabolic diseases relevant to the GCC region.
KAUST and the Center for Epigenetics and Metabolism (CEM) at UC Irvine have formed a partnership to advance epigenetics research, focusing on the interplay between genes and metabolism. The collaboration involves researchers from both institutions, including Professors Valerio Orlando and Pierre J. Magistretti from KAUST, and Professors Paolo Sassone-Corsi and Emiliana Borrelli from UCI. The partnership will include an exchange program for students, post-doctoral fellows, and sabbatical professors, as well as joint KAUST-UC Irvine conferences. Why it matters: This partnership enhances KAUST's research capabilities in fundamental cellular processes and positions the institution at the forefront of epigenetics research in the region.
KAUST researchers are exploring the link between nutrition and brain-energy metabolism to address cognitive decline, dementia, and Alzheimer’s disease. Dr. Pierre Magistretti and Dr. Johannes le Coutre are collaborating on ways to merge brain-energy metabolism research into the field of nutrition. They published an article entitled “Goals in Nutrition Science 2015-2020” in the journal Frontiers in Nutrition. Why it matters: This research could lead to nutritional interventions to hinder or prevent cognitive decline, offering a new approach beyond traditional drug treatments.
KAUST researchers have developed a new synthetic biology process using metabolically engineered algae to produce fragrant sesquiterpenoids, the core compounds in agarwood and other perfumes. The process, developed by the Lauersen and Szekely groups, achieved yields 25 times higher than previous methods and allows for the synthesis of 103 types of fragrant sesquiterpenoids. It also incorporates an energy-efficient nanofiltration step and operates at room temperature with minimal waste. Why it matters: This sustainable bioprocess offers a green alternative to environmentally damaging harvesting of natural resources for the $44 billion fragrance industry, with potential applications in drug development.